Effectiveness and safety of atosiban versus conventional treatment in the management of preterm labor

Kalyoncu, 2010, Neonatal Morbidity and Mortality of late preterm babies, J Matern Fetal Neonatal Med, 23, 607, 10.3109/14767050903229622 Lamont, 2008, Atosiban as a tocolytic for the treatment of spontaneous preterm labor, Expet Rev Obstet Gynecol, 3, 163, 10.1586/17474108.3.2.163 Beck, 2010, The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity, Bull World Health Organ, 88, 31, 10.2471/BLT.08.062554 Goldenberg, 2008, Epidemiology and causes of preterm birth, Lancet, 371, 75, 10.1016/S0140-6736(08)60074-4 Chou, 2011, Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study, Taiwan J Obstet Gynecol, 50, 136, 10.1016/j.tjog.2011.04.003 Steinwall, 2004, Oxytocin mRNA content in the endometrium of non-pregnant women, BJOG, 111, 266, 10.1111/j.1471-0528.2004.00049.x Decleer, 2012, The role of oxytocin antagonists in repeated implantation -failure, Facts Views Vis Obgyn, 4, 227 Duley, 2002 Stokes, 1995 Fullerton, 2011, Atosiban in the management of preterm labour, Clin Med Insights Women's Health, 4, 9, 10.4137/CMWH.S5125 2000 Moutquin, 2001, The worldwide atosiban versus beta-agonists survey group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour, Br J Obstet Gynaecol, 108, 133 Fuchs, 1984, Oxytocin receptors in the human uterus during pregnancy and parturition, Am J Obstet Gynecol, 150, 734, 10.1016/0002-9378(84)90677-X